Practice question

Answer the question and get instant feedback.

HardEndocrinologyType 2 diabetes with CVD - second-line therapyau-racpau-amc

A 64-year-old man with type 2 diabetes, obesity and a previous myocardial infarction is taking metformin at maximum tolerated dose but still has HbA1c 8.0%. eGFR is 60 mL/min/1.73 m². Which additional glucose-lowering medication class is preferred to improve glycaemic control and cardiovascular outcomes?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.